US Broker Ratings

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Valuation Insights Amid Strong Healthcare Sector Performance

Merck & Company, Inc. (NYSE: MRK), a leading player in the healthcare sector, continues to hold significant appeal for investors with its formidable market presence and..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking a 37.78% Potential Upside for Investors

Avantor, Inc. (NYSE: AVTR) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Unveiling a Potential 19.47% Upside in the Healthcare Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a prominent player in the diagnostics and research industry, is making waves with its potential upside of 19.47%. Headquartered in Greifensee,..

Medpace Holdings, Inc. (MEDP): Investor Outlook and Key Insights Amidst a Robust Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) is a notable player in the healthcare sector, particularly within the diagnostics and research industry. With its comprehensive suite of clinical..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Powerhouse with 35.20% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, stands out with a compelling potential upside of 35.20%, according to the latest analyst ratings...

Biogen Inc. (BIIB) Stock Analysis: Exploring a 16.91% Potential Upside Amidst Market Challenges

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector focusing on drug manufacturing, continues to capture investor interest with its dynamic portfolio of therapies..

Humana Inc. (HUM) Stock Analysis: Exploring a 19.31% Potential Upside in the Healthcare Sector

Humana Inc. (HUM) stands as a formidable player in the healthcare plans industry, a sector known for its resilience and steady demand. With a market capitalization..

Summit Therapeutics (SMMT) Stock Analysis: Exploring a Potential 50% Upside in Biotech Innovation

Investors with an eye on the healthcare sector may find Summit Therapeutics Inc. (NASDAQ: SMMT) an intriguing candidate, given its substantial potential upside and innovative developments..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 13.95% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a cornerstone in the healthcare sector, specializes in medical devices and has a robust foothold in the United Kingdom...

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Path Ahead with 6.85% Potential Upside

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector’s Diagnostics & Research industry, holds a commanding presence in the genetic and genomic analysis market. Headquartered..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 32.87% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) has been attracting attention from investors with its significant potential upside of 32.87%. This U.S.-based healthcare giant operates in the..

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 41% Potential Upside with Robust Analyst Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with a striking 41% potential upside...

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring the 21.84% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a leading provider in the global healthcare sector, occupies an essential niche in the medical care facilities industry. With its..

Incyte Corporation (INCY) Stock Analysis: Unpacking the 11.68% Potential Upside for Investors

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, currently offers a compelling investment opportunity with a potential upside of 11.68%. Headquartered in Wilmington,..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth Opportunities with a 4.23% Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the pharmaceutical industry, presents an intriguing proposition for investors seeking stability and income in the healthcare sector. With..

BioNTech SE (BNTX) Stock Analysis: Exploring a 44% Potential Upside Amidst Challenging Metrics

BioNTech SE (NASDAQ: BNTX), a key player in the biotechnology sector, has garnered significant attention from investors seeking opportunities in the healthcare industry. Known for its..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a 15% Upside with Strong Buy Ratings

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the healthcare sector, commanding a robust market capitalization of $105.51 billion. As a leading operator..

GSK plc (GSK) Stock Analysis: Evaluating Growth Prospects with a 1.39% Potential Upside

GSK plc (GSK), a prominent player in the healthcare sector, commands attention with its substantial market cap of $113.29 billion. Headquartered in London, this British multinational..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Analyzing a Potential 34% Upside with Robust Revenue Growth

Investors have long identified Intuitive Surgical, Inc. (NASDAQ: ISRG) as a pioneer in the healthcare sector, specifically within the realm of medical instruments and supplies. The..

Sanofi (SNY) Stock Analysis: Exploring the 19.74% Potential Upside

Sanofi (NASDAQ: SNY), a healthcare giant headquartered in Paris, France, is a key player in the drug manufacturing industry, particularly known for its comprehensive portfolio that..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds